首頁 > 市場調查報告書 > 製藥

消化器

市場調查報告書

商品編碼

2050853

消化器官系統藥物市場：按類型、藥物類別、給藥途徑、應用、分銷管道和地區分類

Digestive Drugs Market, By Type, By Drug Class, By Route of Administration, By Application, By Distribution Channel, And by Region

出版日期: 2026年03月16日 | 出版商:

Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，消化器官系統藥物市場規模將達到 661.748 億美元，到 2033 年將達到 998.973 億美元。預計從 2026 年到 2033 年，該市場將以 6.1% 的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	661.748億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	6.10%	2033年市場規模預測：	998.973億美元

消化器官系統藥物用於緩解胃腸道症狀，例如胃酸逆流、消化不良和大腸激躁症（IBS）。它們也用於治療嚴重的疾病，例如克隆氏症、潰瘍性大腸炎和食道裂孔疝氣。常見的消化器官系統疾病包括腹痛、腹脹、腹瀉、便秘和灼熱等症狀。多種胃腸道藥物用於治療不同的胃腸道疾病。例如，雷尼替丁和奧美拉唑等制酸劑用於治療胃酸倒流和消化不良。另一方面，Budesonide、美沙拉嗪和潑尼松龍等藥物用於治療更嚴重的疾病，例如潰瘍性大腸炎和克隆氏症。消化器官系統藥物生產領域的主要市場參與者包括艾伯維、艾力森製藥、GlaxoSmithKline Plc、鐵木製藥和強生製藥。

市場動態

消化器官系統藥物市場的參與者不斷推出新藥，推動了市場成長。例如，2022年7月，韓國製藥公司JW Pharmaceuticals推出了複方消化器官系統藥物Besticon。本產品由枸櫞酸阿貝林、西甲矽油和解痙藥組成。 Besticon對大腸激躁症、消化不良和其他胃腸道疾病患者有效。同樣，2022年5月，跨國製藥公司百時美施貴寶的Zeposea獲得了美國食品藥物管理局（FDA）的核准，用於治療重度活動性潰瘍性大腸炎（UC）。 Zeposea是一種鞘氨醇-1-磷酸（S1P）受體調變器，可抑制淋巴細胞浸潤腸道。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數對全球消化器官系統藥物市場的主要參與者進行了分析：公司亮點、產品系列、主要特徵、財務表現和策略。
全球消化器官系統藥物市場報告的目標受群眾外包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等行業相關人員相關者。
透過分析全球消化器官系統藥物市場的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第10章競爭格局

市佔率分析
- GlaxoSmithKline plc
- AbbVie Inc.（Allergan）
- Takeda Pharmaceutical Company Limited
- Pfizer Inc
- AstraZeneca plc
- Marksans Pharma
- Tillotts Pharma AG
- Salix Pharmaceuticals
- Otsuka Pharmaceutical Co., Ltd.
- Merck & Co., Inc.
- Lexicon Pharmaceuticals, Inc.
- Bayer AG
- Cadila Healthcare Ltd.
分析師意見

第11章

調查方法
關於本公司

簡介目錄

Product Code: CMI5542

Digestive Drugs Market is estimated to be valued at USD 66,174.8 Mn in 2026 and is expected to reach USD 99,897.3 Mn by 2033, growing at a compound annual growth rate (CAGR) of 6.1% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 66,174.8 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	6.10%	2033 Value Projection:	USD 99,897.3 Mn

Digestive drugs are used to relieve gastrointestinal symptoms such as acid reflux, indigestion, and irritable bowel syndrome (IBS) among others. In addition, it is also used to treat other severe conditions such as Crohn's disease, ulcerative colitis, and hiatal hernia. The common digestive system diseases include symptoms such as abdominal pain, bloating, diarrhoea, constipation and heartburn. There are various gastrointestinal therapeutics that are used for treating various gastrointestinal conditions. For instance, acid reflux and indigestion are treated with antacids such as ranitidine and omeprazole. More severe conditions like ulcerative colitis and Crohn's disease are treated with medications such as budesonide, mesalazine and prednisolone. Few key market players manufacturing gastrointestinal drugs includes AbbVie, Alexion Pharmaceuticals, GlaxoSmithKline, Ironwood Pharmaceuticals and Janssen Pharmaceuticals among others.

Market Dynamics

Companies operating in digestive drugs market are launching new drugs which is contributing to growth of the digestive drugs market. For instance, in July 2022, JW Pharmaceutical, a South Korea based pharmaceutical company, launched Besticon a compound digestive medicine. It is composed of alverine citrate, simethicone and antispasmodic agent. Besticon is effective for patients suffering with irritable bowel syndrome, indigestion and other gastrointestinal issues. Similarly, in May 2022, Bristol Myers Squibb, a multinational pharmaceutical company received the U.S. Food and Drug Administration (FDA) approval for Zeposia for the treatment of severely active ulcerative colitis (UC). It is a sphingosine 1-phosphate (S1P) receptor modulator which reduces lymphocyte migration into the intestines.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global digestive drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, strategies
Key companies covered as a part of this study include GlaxoSmithKline plc, AbbVie Inc. (Allergan), Takeda Pharmaceutical Company Limited, Pfizer Inc, AstraZeneca plc, Marksans Pharma, Tillotts Pharma AG, Salix Pharmaceuticals, Otsuka Pharmaceutical Co., Ltd., Merck & Co., Inc., Lexicon Pharmaceuticals, Inc., Bayer AG, Cadila Healthcare Ltd.
Global digestive drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global digestive drugs market

Market Segmentation

Global Digestive Drugs Market, By Type (Revenue, USD Mn, 2021 - 2033)
Branded
Generic
Global Digestive Drugs Market, By Drug Class (Revenue, USD Mn, 2021 - 2033)
5-aminosalicylates
GI stimulants
Laxatives
Antacids
H2 Antagonists
Antidiarrheals
Others
Global Digestive Drugs Market, By Route of Administration (Revenue, USD Mn, 2021 - 2033)
Oral
Intravenous
Others
Global Digestive Drugs Market, By Application (Revenue, USD Mn, 2021 - 2033)
Gastroesophageal Reflux Disease (GERD)
Irritable Bowel Syndrome
Ulcerative Colitis
Others (Chronic diarrhoea, constipation etc.)
Global Digestive Drugs Market, By Distribution Channel (Revenue, USD Mn, 2021 - 2033)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Digestive Drugs Market, By Region (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Digestive Drugs Market Companies
GlaxoSmithKline plc
AbbVie Inc. (Allergan)
Takeda Pharmaceutical Company Limited
Pfizer Inc
AstraZeneca plc
Marksans Pharma
Tillotts Pharma AG
Salix Pharmaceuticals
Otsuka Pharmaceutical Co., Ltd.
Merck & Co., Inc.
Lexicon Pharmaceuticals, Inc.
Bayer AG
Cadila Healthcare Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Drug Class
- Market Snapshot, By Route of Administration
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Market Trends
New Product Launches
Regulatory Scenario
PORTER's Five Forces Analysis
Business Development Strategies
Epidemiology
Disease Awareness Programs
Treatment Safety and Efficacy Analysis
Pipeline Analysis

4. Global Digestive Drugs Market, By Type, 2026 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Branded
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Mn)
Generic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Mn)

5. Global Digestive Drugs Market, By Drug Class, 2026 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
5-aminosalicylates
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Mn)
GI stimulants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Mn)
Laxatives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Mn)
Antacids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Mn)
H2 Antagonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Mn)
Antidiarrheals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Mn)

6. Global Digestive Drugs Market, By Route of Administration, 2026 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Mn)
Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Mn)

7. Global Digestive Drugs Market, By Application, 2026 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Gastroesophageal Reflux Disease (GERD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Mn)
Irritable Bowel Syndrome
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Mn)
Ulcerative Colitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Mn)
Others (Chronic diarrhoea, constipation etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Mn)

8. Global Digestive Drugs Market, By Distribution Channel, 2026 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Mn)

9. Global Digestive Drugs Market, By Region, 2026 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2026 - 2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Mn)
  - U.K.
  - Germany
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 - 2033, (US$ Mn)
  - North Africa
  - Central Africa
  - South Africa

10. Competitive Landscape

Market Share Analysis
- GlaxoSmithKline plc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- AbbVie Inc. (Allergan)
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Takeda Pharmaceutical Company Limited
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Pfizer Inc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- AstraZeneca plc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Marksans Pharma
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Tillotts Pharma AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Salix Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Otsuka Pharmaceutical Co., Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Merck & Co., Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Lexicon Pharmaceuticals, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Bayer AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Cadila Healthcare Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
Analyst Views